期刊文献+

纯运动不能的临床研究 被引量:1

下载PDF
导出
摘要 目的探讨纯运动不能的临床特点、诊断和治疗。方法总结分析1例纯运动不能的临床资料,并随访观察。结果该例纯运动不能患者主要表现为运动、言语和书写运动障碍,伴眼睑异常,无肌强直或震颤,新斯的明试验症状有改善,多奈哌齐治疗有效,脑深部电刺激和多巴胺能药物治疗无效。结论该患者表现符合纯运动不能的推荐诊断标准,冻结步态的病因确诊需要长期随访或病理诊断。 Objective To explore the characteristics, diagnosis and therapy of pure akinesia. Methods The data of the patient with pure akinesia was analyzed and the patient has been followed for one year. Results Pure akinesia was characterized by freezing of gait, speech and handwriting without tremor or rigidity. Donepezil was effective without response to levodopa. Conclusion The manifestation accord to diagnostic criteria of pureakinesia,and the diagnosis depends on longterm follow-up or pathology.
出处 《当代医学》 2014年第2期112-113,共2页 Contemporary Medicine
关键词 冻结步态 纯运动不能 进行性核上性麻痹 Freezing gait Pure akinesia Progressive
  • 相关文献

参考文献13

  • 1Williams DR,Holton JL,Strand K. Pure akinesia with gait freezing:a third clinical phenotype of progressive supranuclear palsy[J].{H}BMC Neuroscience,2007,(15):2235-2241.
  • 2Factor SA. The clinical spectrum of freezing of gait in atypical parkinsonism[J].{H}Movement Disorders,2008,(11):1639-1640.
  • 3吴萍.纯粹无动症1例报告[J].广州医学院学报,2012,40(3):107-108. 被引量:1
  • 4朱银伟,孙永安,陈俊,肖朝勇,时建铨,张楚楚,江炜炜,张颖冬,徐俊.磁共振帕金森综合征指数在进行性核上性麻痹预后中的价值[J].中华老年心脑血管病杂志,2013,15(3):273-276. 被引量:7
  • 5Imai H. Introduction and comments on the NINDS clinical criteria for the diagnosis of progressive supranuclear palsy[J].{H}No To Shinkei Brain and Nerve,1998,(4):309-316.
  • 6Levy R. Progressive supranuclear palsy:what's new[J].{H}Neurological Sciences,2011,(4):703-705.
  • 7Factor SA,Jennings DL,Molho ES. The natural history of the primary progressive freezing gait[J].{H}Archives of Neurology,2002.1778-1783.
  • 8Yener GG,Kaya GC. Improvement in Tc-99 m HMPAO brain SPECT findings during donepezil therapy in a patient with pure akinesia[J].{H}Annals of Nuclear Medicine,2005,(7):607-609.
  • 9Yamamoto M,Fujii S,Hatanaka Y. Result of long-term administration of L-threo-3,4-dihydroxyphenylserine in patients with pure akinesia as an early symptom of progressive supranuclear palsy[J].{H}Clinical Neuropharmacology,1997,(4):371-373.
  • 10Di Fabio R.Serrao M,Pierelli F. Pure akinesia:a kinematic analysis in a case responsive to rotigotine[J].{H}FUNCTIONAL NEUROLOGY,2013,(2):133-135.

二级参考文献16

  • 1Imai H. Introduction and comments on the NINDS clinical criteria for the diagnosis of progressive supranuclear palsy [J]. No To Shinkei, 1998, 50(4) : 309-316.
  • 2Katayama S. L-DOPA nenresposive pure akinesia due to nigta-internal pallidal degeneration: A clinieopatbological case study [ C ]. In: International Basal Ganglia Society. 5th International Triennial Meeting Abstract. Nemuno- Sato, Mie, 1995: 43.
  • 3Osaki Y,Ben Shlomo Y,Lees AJ,et al. The accuracy of clini cal diagnosis of progressive supranuelear palsy. Movement Disorders, 2004,19 : 181- 189.
  • 4Williams DR,de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven pro gressive supranuclear palsy: Richardson's syndrome and PSP- parkinsonism. Brain,2005,128 : 1247 -1258.
  • 5Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Par kinson disease and the Parkinson variant of multiple system atrophy. Radiology,2008,246:214- 221.
  • 6Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele Rich- ardson-Olszewski syndrome) :report of the NIND-SPSP in ternational workshop. Neurology, 1996,47 : 1 -9.
  • 7Nicoletti G, Fera F, Condino F, et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology, 2006,239 : 825 -830.
  • 8Williams D, Lees A. Progressive supranuelear palsy: clinico pathological concepts and diagnostic challenges. Lancet Neu rol, 2009,8 : 270-279.
  • 9Dickson DW,Ahmed Z,Algom AA,et al. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol, 2010,23 : 394-400.
  • 10Williams DR,Lee W. Clinical features and criteria for the di agnosis of progressive supranuclear palsy. Neurodegener Dis Manag,2012,2: 125 -133.

共引文献6

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部